These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32 related articles for article (PubMed ID: 34919559)
1. Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana. Modongo C; Barilar I; Wang Q; Molefi T; Makhondo T; Niemann S; Shin SS Emerg Infect Dis; 2023 Nov; 29(11):2403-2406. PubMed ID: 37877680 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the Mycobacterium tuberculosis molecular bacterial load assay, microscopy and GeneXpert versus liquid culture for viable bacterial load quantification before and after starting pulmonary tuberculosis treatment. Hai HT; Vinh DN; Thu DDA; Hanh NT; Phu NH; Srinivasan V; Thwaites GE; T T Thuong N Tuberculosis (Edinb); 2019 Dec; 119():101864. PubMed ID: 31568973 [TBL] [Abstract][Full Text] [Related]
3. Blazing the trail for innovative tuberculosis diagnostics. Yerlikaya S; Broger T; Isaacs C; Bell D; Holtgrewe L; Gupta-Wright A; Nahid P; Cattamanchi A; Denkinger CM Infection; 2024 Feb; 52(1):29-42. PubMed ID: 38032537 [TBL] [Abstract][Full Text] [Related]
6. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973 [TBL] [Abstract][Full Text] [Related]
7. Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection. Georghiou SB; Alagna R; Cirillo DM; Carmona S; Ruhwald M; Schumacher SG PLoS One; 2021; 16(12):e0261442. PubMed ID: 34919559 [TBL] [Abstract][Full Text] [Related]
8. The New Xpert MTB/RIF Ultra: Improving Detection of Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D mBio; 2017 Aug; 8(4):. PubMed ID: 28851844 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
10. Accuracy of the Truenat MTB-RIF Dx assay for detection of rifampicin resistance-associated mutations. Georghiou SB; Gomathi NS; Rajendran P; Nagalakshmi V; Prabakaran L; Prem Kumar MM; Macé A; Tripathy S; Ruhwald M; Schumacher SG; Penn-Nicholson A Tuberculosis (Edinb); 2021 Mar; 127():102064. PubMed ID: 33652272 [No Abstract] [Full Text] [Related]
11. An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF. Cayci YT; Bilgin K; Coban AY; Birinci A; Durupınar B Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):756-759. PubMed ID: 29091135 [TBL] [Abstract][Full Text] [Related]
12. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens. Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383 [TBL] [Abstract][Full Text] [Related]